FDA Clearance Tracker · P030016-S001
Visian Toric ICL (IMPLANTABLE COLLAMER LENS)
Last checked: Nov 20, 2026Latest source record: Sep 13, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Sep 13, 2018
Approved
Time to decision
4,521 days
Received Apr 28, 2006. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P030016-S001
- Device name
- Visian Toric ICL (IMPLANTABLE COLLAMER LENS)
- Applicant
- STAAR Surgical Company
- Applicant location
- Monrovia, CA
- Received
- Apr 28, 2006
- Decided
- Sep 13, 2018
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P030016
Device type
- Device type
- Phakic toric intraocular lens (QCB)
- Device class
- Class III
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for the Visian® Toric ICL (Implantable Collamer Lens). The device is indicated for use in patients 21-45 years of age:1) for the correction of myopic astigmatism with spherical equivalent ranging from -3.0D to less than or equal to -15.0D (in the spectacle plane) with cylinder (spectacle plane) of 1.0D to 4.0D;2) for the reduction of myopic astigmatism with spherical equivalent ranging from greater than -15.0D to -20.0D (in the spectacle plane) with cylinder (spectacle plane) 1.0D to 4.0D;3. with an anterior chamber depth (ACD) of 3.00 mm or greater, when measured from the corneal endothelium to the anterior surface of the crystalline lens and a stable refractive history (within 0.5D for both spherical equivalent and cylinder for 1 year prior to implantation); and4) The Visian® TICL is intended for placement in the posterior chamber (ciliary sulcus) of the phakic eye.
Source documents
Other decisions for STAAR Surgical Company
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- EVO/EVO+VISIAN Implantable Collamer LensPMA supplement
P030016-S035 · Decided Mar 25, 2022 · 1,240 days after receipt · Panel Track
Device type: Lens, intraocular, phakic (MTA) · Ophthalmology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.